Showing results (101-110 of 131) with videos related to
Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2024
Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implicationsEster Davis, Shani Avniel-Polak, Shahd Abu-Kamel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast CancerMaya Dadiani, Noa Bossel Ben-Moshe, Shani Paluch-Shimon, et al.Nature|November 1, 2019
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTsWilliam A Flavahan, Yotam Drier, Sarah E Johnstone, et al.Molecular Oncology|April 28, 2025
Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptationMaya Dadiani, Gilgi Friedlander, Gili Perry, et al.Cell Reports|November 30, 2022
Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinomaAnuraag S Parikh, Avishai Wizel, Daniel Davis, et al.Nature Genetics|February 27, 2007
A module of negative feedback regulators defines growth factor signalingIdo Amit, Ami Citri, Tal Shay, et al.Genome Biology|January 28, 2015
Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastomaSebastian Kurscheid, Pierre Bady, Davide Sciuscio, et al.Cancer Research|October 30, 2003
Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypesSophie Godard, Gad Getz, Mauro Delorenzi, et al.Nature Communications|April 16, 2024
Differentiation shifts from a reversible to an irreversible heterochromatin state at the DM1 locusTayma Handal, Sarah Juster, Manar Abu Diab, et al.EMBO Molecular Medicine|November 6, 2012
miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumoursFrancesca Biagioni, Noa Bossel Ben-Moshe, Giulia Fontemaggi, et al.Pageof 14